Nadine Bouziad-Ait
EPFL Innovation Park
Lausanne, VD, Switzerland
Lausanne, VD, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Elimination of tau tangles and soluble aggregates with the small molecule ACI-16664 prevents neurodegeneration in vivo.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: December 09, 2025
Differential role of C-terminal truncations on alpha-synuclein pathology and Lewy body formation.
Journal: NPJ Parkinson's disease
Published: November 10, 2024
An approach to characterize mechanisms of action of anti-amyloidogenic compounds in vitro and in situ.
Journal: NPJ Parkinson's disease
Published: November 06, 2023
Unraveling the complexity of amyloid polymorphism using gold nanoparticles and cryo-EM.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: March 13, 2020
Phosphorylation of the overlooked tyrosine 310 regulates the structure, aggregation, and microtubule- and lipid-binding properties of Tau.
Journal: The Journal of biological chemistry
Published: December 31, 2019
Discovery and characterization of stable and toxic Tau/phospholipid oligomeric complexes.
Journal: Nature communications
Published: November 10, 2016
Microtubule-Binding R3 Fragment from Tau Self-Assembles into Giant Multistranded Amyloid Ribbons.
Journal: Angewandte Chemie (International ed. in English)
Published: September 25, 2015
Fibril growth and seeding capacity play key roles in α-synuclein-mediated apoptotic cell death.
Journal: Cell death and differentiation
Published: December 15, 2014
The novel Parkinson's disease linked mutation G51D attenuates in vitro aggregation and membrane binding of α-synuclein, and enhances its secretion and nuclear localization in cells.
Journal: Human molecular genetics
Published: April 15, 2014
Showing 1-10 of 10
Last Updated: 09/26/2026